The New Zealand Medical Association believes that point-of-care testing needs to be regulated at a national level. It also needs to be supported by adequate clinical governance and quality management systems by those who provide the tests. This will ensure safe, effective, clinically appropriate point of care testing.
“We are in the middle of a pandemic, and point of care testing has dramatically increased,which means right now is the right time to put in place national regulation to safeguard all concerned,” says NZMA Chair Dr Kate Baddock.
“Point-of-care testing, which is the testing and analysis of clinical specimens outside the traditional laboratory and near to or at the site of patient care, is performed in a number of places such as emergency departments, general practice surgeries, pharmacies and now our community based assessment centres and it just makes sense to have national regulation now.
“Currently, point-of-care testing devices are not subject to effective regulation in New Zealand and this poses significant challenges to the consistency, accuracy, recording of, and quality assurance of, testing especially for the patient.”

NZ Psychological Society: Remembering The Past Guides Our Future
New Zealand Olympic Committee: Motherhood In Focus For Wāhine Toa Graduates Ahead Of Mother's Day
Early Childhood New Zealand: Budget 2026 Must Protect The Future Of Quality Early Childhood Education
Creative New Zealand: Aotearoa Manu Take World Art Stage As 61st Venice Biennale Opens
Country Music Honours: 2026 Country Music Honours Finalists Announced
Mana Mokopuna: Children’s Commissioner Welcomes New Youth Mental Health And Suicide Prevention Services In Te Tai Tokerau